US Patent Issued to MINDRANK AI on April 7 for "Aryl ether-substituted heterocyclic compounds as glpir agonists" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,249, issued on April 7, was assigned to MINDRANK AI LTD. (Hangzhou, China).

"Aryl ether-substituted heterocyclic compounds as glpir agonists" was invented by Long Zhang (Hangzhou, China), Zhangming Niu (Hangzhou, China) and Bowen Tang (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel aryl ether substituted heterocyclic compound has GLP1R agonist activity. Specifically, the compound of formula (I) can be used as a GLP1R agonist. The pharmaceutically acceptable salt, solvate, hydrate, isotope substituent or isomer of the compound are also provided. A method for preventing and/or treating diseases related to the GLP1/GLP1R signali...